Dr Erica D Mcarn, PHD | |
2603 Patterson Rd Ste 7, Riverbank, CA 95367-3407 | |
(775) 304-7510 | |
Not Available |
Full Name | Dr Erica D Mcarn |
---|---|
Gender | Female |
Speciality | Psychologist - Clinical |
Location | 2603 Patterson Rd Ste 7, Riverbank, California |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1457895021 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
103T00000X | Psychologist | (* (Not Available)) | Secondary |
103TC0700X | Psychologist - Clinical | PSY32034 (California) | Primary |
Entity Name | Humanizing Healing Psychological Services |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1124606595 PECOS PAC ID: 2062821416 Enrollment ID: O20210514001283 |
News Archive
Nanoparticles are smaller than five nanometres - a nanometre being one millionth of a millimetre - which corresponds approximately to the size of macromolecules. Such tiny particles are very easily absorbed in body cells.
The U.S. Food and Drug Administration has approved a novel genetic test for determining whether patients with breast cancer are good candidates for treatment with the drug Herceptin (trastuzumab).
A new study led by a cardiologist from Brigham and Women's Hospital has assessed the cardiovascular and renal outcomes for ertugliflozin, an SGLT2 inhibitor prescribed for patients with type 2 diabetes to help them control blood sugar levels
Researchers at UT Southwestern Medical Center have discovered a basic mechanism by which smooth muscle cells that line the blood vessels can grow - sometimes abnormally - suggesting methods of treatment for various coronary diseases.
› Verified 6 days ago
Entity Name | Grow Healthcare Group Pc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1154994846 PECOS PAC ID: 1850774746 Enrollment ID: O20220809004080 |
News Archive
Nanoparticles are smaller than five nanometres - a nanometre being one millionth of a millimetre - which corresponds approximately to the size of macromolecules. Such tiny particles are very easily absorbed in body cells.
The U.S. Food and Drug Administration has approved a novel genetic test for determining whether patients with breast cancer are good candidates for treatment with the drug Herceptin (trastuzumab).
A new study led by a cardiologist from Brigham and Women's Hospital has assessed the cardiovascular and renal outcomes for ertugliflozin, an SGLT2 inhibitor prescribed for patients with type 2 diabetes to help them control blood sugar levels
Researchers at UT Southwestern Medical Center have discovered a basic mechanism by which smooth muscle cells that line the blood vessels can grow - sometimes abnormally - suggesting methods of treatment for various coronary diseases.
› Verified 6 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Erica D Mcarn, PHD 2603 Patterson Rd Ste 7, Riverbank, CA 95367-3407 Ph: () - | Dr Erica D Mcarn, PHD 2603 Patterson Rd Ste 7, Riverbank, CA 95367-3407 Ph: (775) 304-7510 |
News Archive
Nanoparticles are smaller than five nanometres - a nanometre being one millionth of a millimetre - which corresponds approximately to the size of macromolecules. Such tiny particles are very easily absorbed in body cells.
The U.S. Food and Drug Administration has approved a novel genetic test for determining whether patients with breast cancer are good candidates for treatment with the drug Herceptin (trastuzumab).
A new study led by a cardiologist from Brigham and Women's Hospital has assessed the cardiovascular and renal outcomes for ertugliflozin, an SGLT2 inhibitor prescribed for patients with type 2 diabetes to help them control blood sugar levels
Researchers at UT Southwestern Medical Center have discovered a basic mechanism by which smooth muscle cells that line the blood vessels can grow - sometimes abnormally - suggesting methods of treatment for various coronary diseases.
› Verified 6 days ago